These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23856243)

  • 1. The meaning of the anti-cancer antibody CLN-IgG (Pritumumab) generated by human × human hybridoma technology against the cyto-skeletal protein, vimentin, in the course of the treatment of malignancy.
    Hugwil AV
    Med Hypotheses; 2013 Sep; 81(3):489-95. PubMed ID: 23856243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of the putative CD44+CD24- breast cancer stem cell population by targeting the polyamine metabolic pathway with PG11047.
    Cirenajwis H; Smiljanic S; Honeth G; Hegardt C; Marton LJ; Oredsson SM
    Anticancer Drugs; 2010 Nov; 21(10):897-906. PubMed ID: 20838207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal immunotherapy with human monoclonal antibody(CLN-IgG) in glioma patients].
    Kubo O; Takakura K
    Nihon Rinsho; 2002 Mar; 60(3):497-503. PubMed ID: 11904965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting cancer stem cells with monoclonal antibodies: a new perspective in cancer therapy and diagnosis.
    Okamoto OK; Perez JF
    Expert Rev Mol Diagn; 2008 Jul; 8(4):387-93. PubMed ID: 18598221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and cancer stem cells.
    Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W
    Cancer Lett; 2014 Apr; 345(2):271-8. PubMed ID: 23941828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptation and learning of molecular networks as a description of cancer development at the systems-level: potential use in anti-cancer therapies.
    Gyurkó DM; Veres DV; Módos D; Lenti K; Korcsmáros T; Csermely P
    Semin Cancer Biol; 2013 Aug; 23(4):262-9. PubMed ID: 23796463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.
    Cronwright G; Le Blanc K; Götherström C; Darcy P; Ehnman M; Brodin B
    Cancer Res; 2005 Mar; 65(6):2207-15. PubMed ID: 15781633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARTS-based anticancer therapy: taking aim at cancer stem cells.
    Elhasid R; Larisch S
    Future Oncol; 2011 Oct; 7(10):1185-94. PubMed ID: 21992730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells.
    Lan L; Luo Y; Cui D; Shi BY; Deng W; Huo LL; Chen HL; Zhang GY; Deng LL
    Int J Oncol; 2013 Jul; 43(1):113-20. PubMed ID: 23604232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of the antigen/epitope that is recognized by human monoclonal antibody CLN-IgG.
    Hagiwara H; Aotsuka Y; Yamamoto Y; Miyahara J; Mitoh Y
    Hum Antibodies; 2001; 10(2):77-82. PubMed ID: 11673662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational targeting of Notch signaling in cancer.
    Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
    Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid cancer development and progression: emerging role of cancer stem cells.
    Malaguarnera R; Morcavallo A; Giuliano S; Belfiore A
    Minerva Endocrinol; 2012 Jun; 37(2):103-15. PubMed ID: 22691885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of vimentin expression in low-density malignant glioma cells as immediate and late effects under irradiation and temozolomide treatment.
    Trog D; Yeghiazaryan K; Schild HH; Golubnitschaja O
    Amino Acids; 2008 May; 34(4):539-45. PubMed ID: 18046501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans.
    Brändlein S; Pohle T; Ruoff N; Wozniak E; Müller-Hermelink HK; Vollmers HP
    Cancer Res; 2003 Nov; 63(22):7995-8005. PubMed ID: 14633732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
    Xia H; Hui KM
    Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cell niche: the place to be.
    Borovski T; De Sousa E Melo F; Vermeulen L; Medema JP
    Cancer Res; 2011 Feb; 71(3):634-9. PubMed ID: 21266356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
    Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of cancer stem cell gene expression.
    Bapat SA
    Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.